Skip to main content
. 2018 Apr 3;10:43. doi: 10.1186/s13148-018-0470-7

Table 3.

Association between mgmiRs and clinicopathological characteristics in HNSCC tissues

mgmiR9-1
%(n)
mgmiR124-1
%(n)
mgmiR124-2
%(n)
mgmiR124-3
%(n)
mgmiR129-2
%(n)
mgmiR137
%(n)
mgmiR148a
%(n)
Combined mgmiRs
%(n)
Location
 OSCC (95) 66.3(63) 72.6(69) 71.6(68) 52.6(50) 73.7(70) 64.2(61) 43.2(41) 92.6(88)
 OPSCC (44) 75(33) 72.7(32) 86.4(38) 50(22) 79.6(35) 61.4(27) 40.9(18) 97.7(43)
 LSCC (48) 56.3(27) 68.8(33) 81.3(39) 43.8(21) 68.8(33) 58.3(28) 50.0(24) 89.6(43)
Smoking
 Never (37) 70.3(26) 67.6(25) 73.0(27) 56.8(21) 64.9(24) 59.5(22) 51.4(19) 89.2(33)
 Current (50) 74.0(37) 76.0(38) 86.0(43) 44.0(22) 74.0(37) 64.0(32) 36.0(18) 96.0(48)
 Ex (78) 64.1(50) 75.6(59) 73.1(57) 53.9(42) 78.2(61) 68.0(53) 46.2(36) 96.2(75)
HPV
 Positive (25) 68.0(17) 68.0(17) 88(22) 72(18) 84.0(21) 52.0(13) 48.0(12) 96(24)
 Negative (41) 51.2(21) 63.4(26) 65.9(27)* 53.7(22) 56.1(23)* 61.0(25) 39.0(16) 80.5(33)*
Tumor size
 T1 (46) 76.0(35) 69.6(32) 65.2(30) 56.5(26) 56.5(26) 63.0(29) 34.8(16) 93.5(43)
 T2 (49) 65.3(32) 77.6(38) 87.8(43) 51.0(25) 83.7(41) 65.3(32) 53.1(26) 95.9(47)
 T3 (41) 58.5(24) 58.5(24) 75.6(31) 39.0(16) 70.7(29) 48.8(20) 36.6(15) 87.8(36)
 T4 (50) 62.0(31) 78.0(39) 80.0(40) 52.0(26) 82.0(41) 68.0(34) 50.0(25) 94.0(47)
Node status
 N0 (78) 69.2(54) 79.5(62)* 76.9(60) 56.4(44) 69.2(54) 60.3(47) 42.3(33) 94.9(74)
 N+ (108) 63.0(68) 65.7(71) 77.8(84) 45.4(49) 76.9(83) 63.0(68) 45.4(49) 91.7(99)
Stage
 I (34) 73.5(25) 73.5(25) 64.7(22) 55.9(19) 55.9(19) 58.8(20) 32.4(11) 91.2(31)
 II (20) 55.0(11) 80.0(16) 85.0(17) 55.0(11) 80.0(16) 75.0(15) 55.0(11) 95.0(19)
 III (59) 67.8(40) 66.1(39) 74.6(44) 44.7(24) 72.9(43) 59.3(35) 37.3(22) 91.5(54)
 IV (73) 63.0(46) 72.6(53) 83.6(61) 53.4(39) 80.8(59) 61.6(45) 52.1(38) 94.5(69)

*p < 0.05